The methods of cerebral infarction revascularization include thrombolytic therapy, interventional therapy and treatment to improve blood circulation. Thrombolytic therapy is mainly applicable to ultra-early patients, such as patients with onset time within six hours, signs and symptoms of severe neurological deficits, no cranial imaging changes, no contraindications to thrombolysis, and suitable for thrombolysis should be given as early as possible. The commonly used drugs for intravenous thrombolysis are alteplase and urokinase. Thrombolytic therapy can rapidly restore cerebral blood flow and improve brain tissue metabolism, which can minimize the signs and symptoms of neurological deficits. Interventional therapy is mainly applied when the patient has an arterial stenosis of 75% or more, mainly endovascular stenting is given. For the treatment of improving blood circulation, the commonly used drugs in clinical practice are Shuxin, Vibrulun, Sparing blood and Chuanxiongzin, etc.